Canine atopic dermatitis is a common, chronic skin disease causing persistent itching, inflammation, and infections. Breakthrough therapies like targeted monoclonal antibodies and next-generation JAK ...

Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today the U.S. Food and Drug ...

MSD Animal Health has presented new clinical trial data showing its oral drug NUMELVI® (atinvicitinib) significantly reduces itching and skin inflammation in dogs with atopic and allergic dermatitis.

Rayne Nutrition, the #1 choice of veterinary dermatologists for novel protein diets relaunches Skin Relief Dry Dog Food. A recent survey of pet owners who had been feeding Rayne Nutrition's Skin ...

Humans aren’t the only ones who suffer from seasonal allergies. When the weather warms up in the spring, many dog owners ...

As allergic dermatitis progresses, quality of life in dogs and the human-animal bond can be significantly impacted due to physical discomfort, emotional distress, and interruptions in sleep and ...

The only JAK inhibitor approved in the U.S. for the control of pruritus associated with allergic dermatitis in dogs six months of age and older RAHWAY, N.J.--(BUSINESS WIRE)-- Merck Animal Health, ...

FDA Approves NUMELVI™ (atinvicitinib tablets) for Dogs from Merck Animal Health – The First and Only Second-Generation Janus Kinase (JAK) Inhibitor for the Control of Pruritus Associated with Allergic ...